- Home
- ASND vs CPB Comparison
ASND vs CPB Comparison
Compare ASND & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- CPB
- Stock Information
- Founded
- ASND 2006
- CPB 1869
- Country
- ASND Denmark
- CPB United States
- Employees
- ASND N/A
- CPB N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- CPB Packaged Foods
- Sector
- ASND Health Care
- CPB Consumer Staples
- Exchange
- ASND Nasdaq
- CPB Nasdaq
- Market Cap
- ASND 10.6B
- CPB 9.2B
- IPO Year
- ASND 2015
- CPB N/A
- Fundamental
- Price
- ASND $170.14
- CPB $33.31
- Analyst Decision
- ASND Strong Buy
- CPB Hold
- Analyst Count
- ASND 17
- CPB 17
- Target Price
- ASND $222.18
- CPB $39.19
- AVG Volume (30 Days)
- ASND 412.4K
- CPB 5.8M
- Earning Date
- ASND 09-02-2025
- CPB 08-28-2025
- Dividend Yield
- ASND N/A
- CPB 4.68%
- EPS Growth
- ASND N/A
- CPB N/A
- EPS
- ASND N/A
- CPB 1.50
- Revenue
- ASND $398,509,511.00
- CPB $10,225,000,000.00
- Revenue This Year
- ASND $77.19
- CPB $7.68
- Revenue Next Year
- ASND $75.84
- CPB N/A
- P/E Ratio
- ASND N/A
- CPB $22.17
- Revenue Growth
- ASND 12.06
- CPB 8.65
- 52 Week Low
- ASND $111.09
- CPB $29.39
- 52 Week High
- ASND $183.00
- CPB $52.81
- Technical
- Relative Strength Index (RSI)
- ASND 47.59
- CPB 61.42
- Support Level
- ASND $165.24
- CPB $30.70
- Resistance Level
- ASND $179.96
- CPB $31.53
- Average True Range (ATR)
- ASND 6.21
- CPB 0.90
- MACD
- ASND -1.07
- CPB 0.33
- Stochastic Oscillator
- ASND 33.20
- CPB 95.38
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About CPB Campbell Soup Company
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2024 (July year-end), snacks accounted for nearly half of its revenue, followed by soup (28%), other simple meals (17%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in March 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.